光生物调节与中度或高强度间歇训练相结合,对心力衰竭患者的氧气消耗和运动耐受性进行调节
Diego Busin1, Leandro Tolfo Franzoni2, Douglas Turella3
1Programa de Pós-Graduação em Ciências da Reabilitação - Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS - Brasil.
Arquivos brasileiros de cardiologia
|January 15, 2026
概括
高强度有氧训练 (AT) 显著改善心力衰竭 (HF) 患者的运动表现. 将光生物调节疗法 (PBMT) 添加到AT并没有为这些患者提供额外的益处.
科学领域:
- 心血管康复心血管康复
- 运动生理学 运动生理学
- 照相医疗 (photomedicine) 是一种医学.
背景情况:
- 有氧训练 (AT) 是心力衰竭 (HF) 患者心血管康复的基石.
- 光生物调节疗法 (PBMT) 显示出增强运动表现的前景,但其在HF人群中的有效性尚未得到充分证实.
研究的目的:
- 为了确定PBMT与中度或高强度AT的结合是否会改善HF患者的心肺运动能力.
主要方法:
- 一项非随机临床试验,涉及49名HF患者 (排泄分数<40%),分五组:单独中度AT,中度AT+PBMT,单独高强度AT,高强度AT+PBMT和对照组.
- 10周的干预期,随后进行心肺运动测试,以评估VO2峰值,呼吸效率和运动耐受性.
- 使用概括估计方程进行统计分析,其显著程度为p < 0.05.
主要成果:
- 所有的训练组都在运动速度和等级上有所改善,高强度的AT产生了最显著的收益.
- 高强度AT组的氧气消耗显著增加 (1.80ml.kg-1.min-1,p = 0.002) 并增加了疲劳的时间.
- 当PBMT与中度或高强度的AT结合使用时,没有观察到任何显著的额外益处.
结论:
- 高强度有氧训练在改善心力衰竭患者的运动性能方面是有效的.
- 在本研究中应用的PBMT的添加并没有增强HF患者的AT的益处.
- 建议使用优化的PBMT协议进行进一步的研究,以探索其在HF康复中的潜力.
相关概念视频
Exercise and Cardiac Output
1.8K
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
Sustained exercise increases the muscles' oxygen demand, which can be...
1.8K
Heart Failure VI: Adjunct Therapies
261
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
261
Heart Failure II: Pathophysiology
730
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
730
Exercise and Cardiovascular Response
3.9K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
3.9K
Heart Failure V: Medical Management
223
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
223
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
589
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
589


